Terguride stimulates locomotor activity at 2 months but not 10 months after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets
- 3 March 1992
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 212 (2-3) , 247-252
- https://doi.org/10.1016/0014-2999(92)90337-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437European Journal of Pharmacology, 1989
- Terguride—a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptineFertility and Sterility, 1988
- The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey modelEuropean Journal of Pharmacology, 1988
- Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmosetMovement Disorders, 1987
- Chronic Treatment of Pathological Hyperprolactinemia and Acromegaly with the New Ergot Derivative Terguride*Journal of Clinical Endocrinology & Metabolism, 1986
- Therapeutic efficacy of a partial dopamine agonist in drug-free parkinsonian patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmosetNeuroscience Letters, 1984
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976